A dose of doubt: a qualitative study on placebo regulations
IntroductionPlacebo use is common in primary care, yet ethical and legal concerns persist, and few qualitative studies have explored physicians’ views on placebo regulation.MethodsWe conducted semi-structured interviews with 10 primary care physicians from 2 German-speaking Swiss cantons to explore...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1574022/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850101752384192512 |
|---|---|
| author | Mélina Richard Mélina Richard Manuela Ganz Bernice S. Elger Bernice S. Elger Jens Gaab |
| author_facet | Mélina Richard Mélina Richard Manuela Ganz Bernice S. Elger Bernice S. Elger Jens Gaab |
| author_sort | Mélina Richard |
| collection | DOAJ |
| description | IntroductionPlacebo use is common in primary care, yet ethical and legal concerns persist, and few qualitative studies have explored physicians’ views on placebo regulation.MethodsWe conducted semi-structured interviews with 10 primary care physicians from 2 German-speaking Swiss cantons to explore their definitions of placebos, usage in clinical practice, knowledge of existing regulations, and attitudes toward potential regulatory frameworks. Participants were recruited from a publicly available physician registry, yielding a 4.9% response rate.ResultsParticipants consistently reported using at least impure placebos in their practice, while references to the use of pure placebos were relatively uncommon. A distinction between pure and impure placebos emerged, with the latter generally viewed as more ethically acceptable. Risk-benefit evaluation was emphasized as the primary justification for placebo use. Most participants had not actively sought legal information, and knowledge about current regulations varied considerably. While clear support for specific regulation was rare, most participants did not perceive it as necessary, often citing distrust in regulatory systems or concerns that formal rules could restrict therapeutic flexibility. Expert bodies such as the Swiss Medical Association were mentioned as potential sources of guidance.DiscussionThe findings highlight a practice-oriented, risk-benefit-driven approach to placebo use, shaped by skepticism toward regulation and limited legal awareness. Despite frequent use, physicians operate in a legally ambiguous space and express limited demand for regulatory clarity, suggesting a need for targeted professional discourse rather than strict formal regulation. |
| format | Article |
| id | doaj-art-d7725319ae594e1a8dc7d419dfeeb9db |
| institution | DOAJ |
| issn | 2296-858X |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj-art-d7725319ae594e1a8dc7d419dfeeb9db2025-08-20T02:39:55ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-06-011210.3389/fmed.2025.15740221574022A dose of doubt: a qualitative study on placebo regulationsMélina Richard0Mélina Richard1Manuela Ganz2Bernice S. Elger3Bernice S. Elger4Jens Gaab5Institute for Biomedical Ethics, University of Basel, Basel, SwitzerlandDepartment of Biomedical Engineering, University of Basel, Basel, SwitzerlandDivision of Clinical Psychology and Psychotherapy, Faculty of Psychology, University of Basel, Basel, SwitzerlandInstitute for Biomedical Ethics, University of Basel, Basel, SwitzerlandCenter for Legal Medicine, Faculty of Medicine, University of Geneva, Geneva, SwitzerlandDivision of Clinical Psychology and Psychotherapy, Faculty of Psychology, University of Basel, Basel, SwitzerlandIntroductionPlacebo use is common in primary care, yet ethical and legal concerns persist, and few qualitative studies have explored physicians’ views on placebo regulation.MethodsWe conducted semi-structured interviews with 10 primary care physicians from 2 German-speaking Swiss cantons to explore their definitions of placebos, usage in clinical practice, knowledge of existing regulations, and attitudes toward potential regulatory frameworks. Participants were recruited from a publicly available physician registry, yielding a 4.9% response rate.ResultsParticipants consistently reported using at least impure placebos in their practice, while references to the use of pure placebos were relatively uncommon. A distinction between pure and impure placebos emerged, with the latter generally viewed as more ethically acceptable. Risk-benefit evaluation was emphasized as the primary justification for placebo use. Most participants had not actively sought legal information, and knowledge about current regulations varied considerably. While clear support for specific regulation was rare, most participants did not perceive it as necessary, often citing distrust in regulatory systems or concerns that formal rules could restrict therapeutic flexibility. Expert bodies such as the Swiss Medical Association were mentioned as potential sources of guidance.DiscussionThe findings highlight a practice-oriented, risk-benefit-driven approach to placebo use, shaped by skepticism toward regulation and limited legal awareness. Despite frequent use, physicians operate in a legally ambiguous space and express limited demand for regulatory clarity, suggesting a need for targeted professional discourse rather than strict formal regulation.https://www.frontiersin.org/articles/10.3389/fmed.2025.1574022/fullplacebo useprimary care physiciansclinical decision-makinghealthcare regulationmedical ethics |
| spellingShingle | Mélina Richard Mélina Richard Manuela Ganz Bernice S. Elger Bernice S. Elger Jens Gaab A dose of doubt: a qualitative study on placebo regulations Frontiers in Medicine placebo use primary care physicians clinical decision-making healthcare regulation medical ethics |
| title | A dose of doubt: a qualitative study on placebo regulations |
| title_full | A dose of doubt: a qualitative study on placebo regulations |
| title_fullStr | A dose of doubt: a qualitative study on placebo regulations |
| title_full_unstemmed | A dose of doubt: a qualitative study on placebo regulations |
| title_short | A dose of doubt: a qualitative study on placebo regulations |
| title_sort | dose of doubt a qualitative study on placebo regulations |
| topic | placebo use primary care physicians clinical decision-making healthcare regulation medical ethics |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2025.1574022/full |
| work_keys_str_mv | AT melinarichard adoseofdoubtaqualitativestudyonplaceboregulations AT melinarichard adoseofdoubtaqualitativestudyonplaceboregulations AT manuelaganz adoseofdoubtaqualitativestudyonplaceboregulations AT berniceselger adoseofdoubtaqualitativestudyonplaceboregulations AT berniceselger adoseofdoubtaqualitativestudyonplaceboregulations AT jensgaab adoseofdoubtaqualitativestudyonplaceboregulations AT melinarichard doseofdoubtaqualitativestudyonplaceboregulations AT melinarichard doseofdoubtaqualitativestudyonplaceboregulations AT manuelaganz doseofdoubtaqualitativestudyonplaceboregulations AT berniceselger doseofdoubtaqualitativestudyonplaceboregulations AT berniceselger doseofdoubtaqualitativestudyonplaceboregulations AT jensgaab doseofdoubtaqualitativestudyonplaceboregulations |